These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31140867)

  • 1. KRAS
    Cagir A; Azmi AS
    Future Med Chem; 2019 May; 11(9):923-925. PubMed ID: 31140867
    [No Abstract]   [Full Text] [Related]  

  • 2. Design of Small Molecules That Compete with Nucleotide Binding to an Engineered Oncogenic KRAS Allele.
    Zhang Y; Larraufie MH; Musavi L; Akkiraju H; Brown LM; Stockwell BR
    Biochemistry; 2018 Feb; 57(8):1380-1389. PubMed ID: 29313669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective Targeting of the KRAS G12C Mutant: Kicking KRAS When It's Down.
    Hobbs GA; Wittinghofer A; Der CJ
    Cancer Cell; 2016 Mar; 29(3):251-253. PubMed ID: 26977877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-Molecule Inhibitors Directly Targeting KRAS as Anticancer Therapeutics.
    Chen H; Smaill JB; Liu T; Ding K; Lu X
    J Med Chem; 2020 Dec; 63(23):14404-14424. PubMed ID: 33225706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Basis for Allosteric Inhibition of GTP-Bound H-Ras Protein by a Small-Molecule Compound Carrying a Naphthalene Ring.
    Matsumoto S; Hiraga T; Hayashi Y; Yoshikawa Y; Tsuda C; Araki M; Neya M; Shima F; Kataoka T
    Biochemistry; 2018 Sep; 57(36):5350-5358. PubMed ID: 30141910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Kras
    Christensen JG; Olson P; Briere T; Wiel C; Bergo MO
    J Intern Med; 2020 Aug; 288(2):183-191. PubMed ID: 32176377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in targeting RAS with small molecule drugs.
    McCormick F
    Biochem J; 2019 Jan; 476(2):365-374. PubMed ID: 30705085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting mutated GTPase KRAS in tumor therapies.
    Fan G; Lou L; Song Z; Zhang X; Xiong XF
    Eur J Med Chem; 2021 Dec; 226():113816. PubMed ID: 34520956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecule binding sites on the Ras:SOS complex can be exploited for inhibition of Ras activation.
    Winter JJ; Anderson M; Blades K; Brassington C; Breeze AL; Chresta C; Embrey K; Fairley G; Faulder P; Finlay MR; Kettle JG; Nowak T; Overman R; Patel SJ; Perkins P; Spadola L; Tart J; Tucker JA; Wrigley G
    J Med Chem; 2015 Mar; 58(5):2265-74. PubMed ID: 25695162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Discovery by Targeting Mutant KRAS.
    Ye N
    Curr Top Med Chem; 2019; 19(23):2079-2080. PubMed ID: 31762422
    [No Abstract]   [Full Text] [Related]  

  • 11. The path to the clinic: a comprehensive review on direct KRAS
    Kwan AK; Piazza GA; Keeton AB; Leite CA
    J Exp Clin Cancer Res; 2022 Jan; 41(1):27. PubMed ID: 35045886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative Systems Pharmacology Analysis of KRAS G12C Covalent Inhibitors.
    Stites EC; Shaw AS
    CPT Pharmacometrics Syst Pharmacol; 2018 May; 7(5):342-351. PubMed ID: 29484842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring Targeted Degradation Strategy for Oncogenic KRAS
    Zeng M; Xiong Y; Safaee N; Nowak RP; Donovan KA; Yuan CJ; Nabet B; Gero TW; Feru F; Li L; Gondi S; Ombelets LJ; Quan C; Jänne PA; Kostic M; Scott DA; Westover KD; Fischer ES; Gray NS
    Cell Chem Biol; 2020 Jan; 27(1):19-31.e6. PubMed ID: 31883964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting cancer with small-molecule pan-KRAS degraders.
    Popow J; Farnaby W; Gollner A; Kofink C; Fischer G; Wurm M; Zollman D; Wijaya A; Mischerikow N; Hasenoehrl C; Prokofeva P; Arnhof H; Arce-Solano S; Bell S; Boeck G; Diers E; Frost AB; Goodwin-Tindall J; Karolyi-Oezguer J; Khan S; Klawatsch T; Koegl M; Kousek R; Kratochvil B; Kropatsch K; Lauber AA; McLennan R; Olt S; Peter D; Petermann O; Roessler V; Stolt-Bergner P; Strack P; Strauss E; Trainor N; Vetma V; Whitworth C; Zhong S; Quant J; Weinstabl H; Kuster B; Ettmayer P; Ciulli A
    Science; 2024 Sep; 385(6715):1338-1347. PubMed ID: 39298590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor.
    Janes MR; Zhang J; Li LS; Hansen R; Peters U; Guo X; Chen Y; Babbar A; Firdaus SJ; Darjania L; Feng J; Chen JH; Li S; Li S; Long YO; Thach C; Liu Y; Zarieh A; Ely T; Kucharski JM; Kessler LV; Wu T; Yu K; Wang Y; Yao Y; Deng X; Zarrinkar PP; Brehmer D; Dhanak D; Lorenzi MV; Hu-Lowe D; Patricelli MP; Ren P; Liu Y
    Cell; 2018 Jan; 172(3):578-589.e17. PubMed ID: 29373830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computationally Empowered Workflow Identifies Novel Covalent Allosteric Binders for KRAS
    Mortier J; Friberg A; Badock V; Moosmayer D; Schroeder J; Steigemann P; Siegel F; Gradl S; Bauser M; Hillig RC; Briem H; Eis K; Bader B; Nguyen D; Christ CD
    ChemMedChem; 2020 May; 15(10):827-832. PubMed ID: 32237114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel quinazoline-based covalent inhibitors of KRAS G12C with various cysteine-targeting warheads as potential anticancer agents.
    Li L; Zhao H; Liao H; Chen J; Liu J; Chen J
    Bioorg Chem; 2021 May; 110():104825. PubMed ID: 33774492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMR in integrated biophysical drug discovery for RAS: past, present, and future.
    Marshall CB; KleinJan F; Gebregiworgis T; Lee KY; Fang Z; Eves BJ; Liu NF; Gasmi-Seabrook GMC; Enomoto M; Ikura M
    J Biomol NMR; 2020 Nov; 74(10-11):531-554. PubMed ID: 32804298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hitting KRAS When It's Down.
    Gabizon R; London N
    J Med Chem; 2020 Jul; 63(13):6677-6678. PubMed ID: 32568546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct KRAS inhibition: progress, challenges, and a glimpse into the future.
    Grapsa D; Syrigos K
    Expert Rev Anticancer Ther; 2020 Jun; 20(6):437-440. PubMed ID: 32320301
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.